Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Sarah M Rieschl
Introduction
Sarah M Rieschl is a notable inventor based in Brooklyn Park, MN (US). She has made significant strides in the pharmaceutical field, particularly with her innovative work on orally disintegrating tablets. Her contributions are aimed at improving treatment methods for proliferative disorders, including cancer.
Latest Patents
Rieschl holds a patent for an orally disintegrating tablet comprising an amorphous solid dispersion of nilotinib. This patent details pharmaceutical compositions that can be used in methods of treating various proliferative disorders. The unique aspect of her invention is that it allows for administration without regard to food consumption. Additionally, her formulation can be administered at a significantly lower dose compared to commercially available immediate-release nilotinib formulations, while still providing a comparable therapeutic effect.
Career Highlights
Sarah M Rieschl is associated with Nanocopoeia, LLC, where she continues to develop innovative pharmaceutical solutions. Her work is characterized by a commitment to enhancing patient care through effective drug delivery systems.
Collaborations
Rieschl collaborates with notable colleagues, including Christian F Wertz and Tzehaw Chen, who contribute to her research and development efforts.
Conclusion
Sarah M Rieschl's innovative work in the pharmaceutical industry exemplifies the impact of dedicated inventors on healthcare solutions. Her patent for an orally disintegrating tablet represents a significant advancement in cancer treatment methodologies.